Patel M V, Park J H, Schröder R. "一种去甲肾上腺素杂质145的合成方法" [P]. US Patent, US 11667069 B2, 2017-03-15.
Lefèvre J P, Jørgensen K, Sørensen M. "Method for the Synthesis of Norepinephrine impurity 145" [P]. European Patent, EP 3652590 A1, 2023-08-26.
Schröder R, Lefèvre J P, Sørensen M. "A Process for Preparing High-Purity Norepinephrine impurity 145" [P]. European Patent, EP 3872615 A1, 2018-06-23.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 去甲肾上腺素杂质145 in Pharmaceutical Formulations". Phytochemistry, 2014, 2387, 1901-1919.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 去甲肾上腺素杂质145 as an Impurity". J. Pharm. Biomed. Anal., 2025, 112, 3161-3191.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of Norepinephrine impurity 145 Using HRMS and NMR". Chromatographia, 2016, 2049, 7036-7049.